Periodontal Therapeutics Market Is Anticipated to Expand at a CAGR of 9.0% from 2018 to 2026
Periodontal therapeutics are products used in the treatment of periodontal diseases. These products include systemic antibiotics such as doxycycline, minocycline, metronidazole, and amoxicillin and locally applied antibiotics such as Arestin, Atridox, and PerioChip. These antibiotics can either be administered to patients orally or delivered directly to dental pockets, without systemic doses. The global Periodontal Therapeutics Market was valued at around US$ 500 Mn in 2017 and is anticipated to expand at a CAGR of more than 9.0% from 2018 to...
View full press release